{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:40:18Z","timestamp":1775842818796,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40121-022-00703-y","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T05:02:29Z","timestamp":1665810149000},"page":"2205-2217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Efficacy of Bacillus Calmette\u2013Gu\u00e9rin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial"],"prefix":"10.1007","volume":"11","clinical-trial-number":[{"clinical-trial-number":"ctri\/2020\/07\/026668","registry":"10.18810\/clinical-trial-registry-india"}],"author":[{"given":"Sanjeev","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Ajayababu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Thukral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhasish Kamal","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayan","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavendra","family":"Lingaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvashi B.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipankar","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveet","family":"Wig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolan Champa","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaswati","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banya","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niraj","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Mohan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"703_CR1","unstructured":"WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. https:\/\/covid19.who.int\/table."},{"issue":"9","key":"703_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","volume":"34","author":"CS Benn","year":"2013","unstructured":"Benn CS, Netea MG, Selin LK, Aaby P. A small jab\u2014a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013;34(9):431\u20139. https:\/\/doi.org\/10.1016\/j.it.2013.04.004 (Epub 2013 May 14; PMID: 23680130).","journal-title":"Trends Immunol"},{"issue":"21\u201322","key":"703_CR3","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/s0264-410x(03)00181-6","volume":"21","author":"ML Garly","year":"2003","unstructured":"Garly ML, Martins CL, Bal\u00e9 C, et\u00a0al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A nonspecific beneficial effect of BCG? Vaccine. 2003;21(21\u201322):2782\u201390. https:\/\/doi.org\/10.1016\/s0264-410x(03)00181-6 (PMID: 12798618).","journal-title":"Vaccine"},{"issue":"2","key":"703_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby P, Roth A, Ravn H, et\u00a0al. Randomised trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011;204(2):245\u201352. https:\/\/doi.org\/10.1093\/infdis\/jir240 (PMID: 21673035).","journal-title":"J Infect Dis"},{"issue":"10","key":"703_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","volume":"23","author":"LG Stensballe","year":"2005","unstructured":"Stensballe LG, Nante E, Jensen IP, et\u00a0al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case\u2013control study. Vaccine. 2005;23(10):1251\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.006 (PMID: 15652667).","journal-title":"Vaccine"},{"issue":"1","key":"703_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts RJW, Moorlag SJCFM, Novakovic B, et\u00a0al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89-100.e5. https:\/\/doi.org\/10.1016\/j.chom.2017.12.010 (PMID: 29324233).","journal-title":"Cell Host Microbe"},{"issue":"1","key":"703_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","volume":"10","author":"J Walk","year":"2019","unstructured":"Walk J, de Bree LCJ, Graumans W, et\u00a0al. Outcomes of controlled human malaria infection after BCG vaccination. Nat Commun. 2019;10(1):874. https:\/\/doi.org\/10.1038\/s41467-019-08659-3 (PMID: 30787276; PMCID: PMC6382772).","journal-title":"Nat Commun"},{"issue":"3","key":"703_CR8","first-page":"185","volume":"43","author":"DEA Wardhana","year":"2011","unstructured":"Wardhana DEA, Sultana A, Mandang VV, Jim E. The efficacy of Bacillus Calmette\u2013Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly. Acta Med Indones. 2011;43(3):185\u201390 (PMID: 21979284).","journal-title":"Acta Med Indones"},{"issue":"1","key":"703_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3143\/geriatrics.42.34","volume":"42","author":"T Ohrui","year":"2005","unstructured":"Ohrui T, Nakayama K, Fukushima T, Chiba H, Sasaki H. Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations. Nihon Ronen Igakkai Zasshi. 2005;42(1):34\u20136. https:\/\/doi.org\/10.3143\/geriatrics.42.34 (Japanese; PMID: 15732353).","journal-title":"Nihon Ronen Igakkai Zasshi."},{"issue":"3","key":"703_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/vaccines8030378","volume":"8","author":"D Klinger","year":"2020","unstructured":"Klinger D, Blass I, Rappoport N, Linial M. Significantly improved COVID-19 outcomes in countries with higher BCG vaccination coverage: a multivariable analysis. Vaccines (Basel). 2020;8(3):378. https:\/\/doi.org\/10.3390\/vaccines8030378 (PMID: 32664505; PMCID: PMC7563451).","journal-title":"Vaccines (Basel)"},{"key":"703_CR11","doi-asserted-by":"publisher","unstructured":"Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study [Preprint] https:\/\/doi.org\/10.1101\/2020.03. 24.20042937. Posted March. 2020;28.","DOI":"10.1101\/2020.03"},{"issue":"12","key":"703_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632478","volume":"8","author":"M Gonzalez-Perez","year":"2021","unstructured":"Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J. The BCG vaccine for COVID-19: first verdict and future directions. Front Immunol. 2021;8(12): 632478. https:\/\/doi.org\/10.3389\/fimmu.2021.632478 (PMID: 33763077; PMCID: PMC7982405).","journal-title":"Front Immunol"},{"key":"703_CR13","unstructured":"US Food and Drug Administration. FDA guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. Table A, Local Reaction to Injectable Product. Rockville, MD: FDA. 2007."},{"issue":"2","key":"703_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","volume":"183","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Tsilika M, Moorlag S, et\u00a0al. Activate randomised clinical trial of BCG vaccination against infection in the elderly. Cell. 2020;183(2):315-323.e9. https:\/\/doi.org\/10.1016\/j.cell.2020.08.051 (Epub 2020 September 1. PMID: 32941801; PMCID: PMC7462457).","journal-title":"Cell"},{"key":"703_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.20.21257520","author":"M Tsilika","year":"2021","unstructured":"Tsilika M, Taks E, Dolianitis K, Kotsaki A, Leventogiannis K, Damoulari C, Kostoula M, Paneta M, Adamis G, Papanikolaou I, Stamatelopoulos K, Bolanou A, Katsaros K, Delavinia C, Perdios I, Pandi A, Tsiakos K, Proios N, Kalogianni E, Giamarellos-Bourboulis E. ACTIVATE-2: a double-blind randomised trial of BCG vaccination against COVID-19 in individuals at risk. Front Immun. 2021. https:\/\/doi.org\/10.1101\/2021.05.20.21257520 (Preprint).","journal-title":"Front Immun"},{"key":"703_CR16","doi-asserted-by":"publisher","first-page":"841868","DOI":"10.3389\/fimmu.2022.841868","volume":"12","author":"LRB dos Anjos","year":"2022","unstructured":"dos Anjos LRB, da Costa AC, Cardoso ADRO, Guimar\u00e3es RA, Rodrigues RL, Ribeiro KM. Efficacy and safety of BCG vaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial. Front Immunol. 2022;12:841868. https:\/\/doi.org\/10.3389\/fimmu.2022.841868.","journal-title":"Front Immunol"},{"key":"703_CR17","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.eclinm.2022.101414","volume":"48","author":"CM Upton","year":"2022","unstructured":"Upton CM, van Wijk RC, Mockeliunas L, et\u00a0al. BCG CORONA Consortium. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101414 (Epub 2022 May 12. PMID: 35582122; PMCID: PMC9098089).","journal-title":"EClinicalMedicine."},{"issue":"2","key":"703_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/vaccines10020314","volume":"10","author":"H Czajka","year":"2022","unstructured":"Czajka H, Zapolnik P, Krzych \u0141, et\u00a0al. A multi-center, randomised, double-blind, placebo-controlled phase III clinical trial evaluating the impact of BCG re-vaccination on the incidence and severity of SARS-CoV-2 infections among symptomatic healthcare professionals during the COVID-19 pandemic in Poland \u2013 first results. Vaccines (Basel). 2022;10(2):314. https:\/\/doi.org\/10.3390\/vaccines10020314 (PMID: 35214772; PMCID: PMC8879775).","journal-title":"Vaccines (Basel)"},{"issue":"369","key":"703_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","volume":"22","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et\u00a0al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;22(369): m1966. https:\/\/doi.org\/10.1136\/bmj.m1966 (PMID: 32444366; PMCID: PMC7243801).","journal-title":"BMJ"},{"issue":"16","key":"703_CR20","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciaa539","volume":"71","author":"L Hu","year":"2020","unstructured":"Hu L, Chen S, Fu Y, et\u00a0al. Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized patients in Wuhan. China Clin Infect Dis. 2020;71(16):2089\u201398. https:\/\/doi.org\/10.1093\/cid\/ciaa539 (PMID: 32361738; PMCID: PMC7197620).","journal-title":"China Clin Infect Dis"},{"issue":"20","key":"703_CR21","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","volume":"384","author":"SA Madhi","year":"2021","unstructured":"Madhi SA, Baillie V, Cutland CL, et\u00a0al. Wits-VIDA COVID Group. Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B1351 variant. N Engl J Med. 2021;384(20):1885\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2102214 (Epub 2021 March 16. PMID: 33725432; PMCID: PMC7993410).","journal-title":"N Engl J Med"},{"issue":"10277","key":"703_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Costa Clemens SA, Madhi SA, et\u00a0al. Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(21)00432-3 (Epub 2021 February 19. Erratum in: Lancet. 2021 March 6;397(10277):880. PMID: 33617777; PMCID: PMC7894131).","journal-title":"Lancet"},{"issue":"10317","key":"703_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(21)02000-6","volume":"398","author":"R Ella","year":"2021","unstructured":"Ella R, Reddy S, Blackwelder W, et\u00a0al. COVAXIN Study Group. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021;398(10317):2173\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(21)02000-6.","journal-title":"Lancet"},{"issue":"3","key":"703_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(21)00674-5","volume":"22","author":"D Desai","year":"2022","unstructured":"Desai D, Khan AR, Soneja M, et\u00a0al. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case\u2013control study. Lancet Infect Dis. 2022;22(3):349\u201356. https:\/\/doi.org\/10.1016\/S1473-3099(21)00674-5 (Epub 2021 November 23. PMID: 34826383; PMCID: PMC8610201).","journal-title":"Lancet Infect Dis"}],"updated-by":[{"DOI":"10.1007\/s40121-023-00770-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000}}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00703-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T07:51:41Z","timestamp":1676533901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00703-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00703-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40121-023-00770-9","asserted-by":"object"}]},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"31 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40121-023-00770-9","URL":"https:\/\/doi.org\/10.1007\/s40121-023-00770-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}